EXHIBIT 10.24
OSI Pharmaceuticals, Inc.
00 Xxxxx Xxxxxxx Xxxx, Xxxxx 000
Xxxxxxxx, XX 00000
T 631.962.2000 F 631.752.3880
xxx.xxxx.xxx
[(OSI)(TM) PHARMACEUTICALS LOGO)]
January 11, 2004
VIA FEDERAL EXPRESS
Xxxx X. XxXxxxxx, D.Xxxx.
Vice President, Business Development
Structural GenomiX, Inc.
00000 Xxxxxxx Xxxxxx
Xxx Xxxxx, XX 00000
Re: Collaboration Agreement dated August 1, 2003 between Structural
GenomiX, Inc. and OSI Pharmaceuticals, Inc.
Dear Xxxx:
This letter confirms acceptance by Structural GenomiX of an amendment to Section
2.8(b) of the above-referenced Collaboration Agreement whereby effective
immediately, OSI Pharmaceuticals shall have the option to increase its
membership on the Joint Steering Committee (JSC) to three (3) representatives,
one of whom shall be a non-voting representative.
Please indicate your agreement by signing two copies and returning one copy to
my attention at OSI Pharmaceuticals, Inc.
Regards,
/s/ Xxxxxxx X. Xxxxxxxx
Xxxxxxx X. Xxxxxxxx
Director, Corporate Development
Agreed and Accepted:
STRUCTURAL GENOMIX, INC.
Name: /s/Xxxxxxx X. Xxxxxx
----------------------------------------
Title: Vice President, Finance
---------------------------------------
Date: 2/26/04
----------------------------------------
Copy: X. Xxxxxx
X. Xxxxxx
X. Xxxxxxxxxx
X. Xxxx
